Blowout Earnings, Revenue Beat Push Regeneron Stock Higher

REGN'S Covid-19 antibody treatment generated $145 million in sales

Digital Content Manager
Feb 5, 2021 at 10:22 AM
facebook X logo linkedin

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are up 2.3% to trade at $510.38 this morning, after the company reported better-than-expected fourth-quarter earnings of $9.53 per share -- significantly higher than Wall Street's estimates of $8.39 per share -- as well as a revenue beat. The pharmaceutical concern also posted a 45% rise in profits, as demand for eye drug Eylea recovered, while its Covid-19 antibody treatment generated $145 million in sales.   

Digging deeper, the security has been taking a breather from its July 20, all-time high of $664.64. Recent rejection at the $560 mark, combined with long-term resistance from the 120-day moving average, have capped additional gains over the past several months. Year-over-year, though, REGN is up 28.9%.

Analysts are majorly optimistic towards Regeneron stock, with 14 of the 20 in coverage sporting a "strong buy" rating. Plus, the 12-month consensus target price of $661.36 is a whopping 32.6% premium to current levels.

An unwinding of pessimism in the options pits could keep the wind at the equity's back. This is per REGN's Schaeffer's put/call open interest ratio (SOIR) of 1.06, which stands higher than 94% of readings in its annual range, suggesting short-term option players have rarely been more put-biased.

That shifts seems to be already happening today. So far, more than 1,900 calls have already crossed the tape, which is six times what is typically seen at this point. Most popular is the weekly -- and expiring -- 2/5 510-strike call, followed by the monthly August 495 call.

Now may be the right time to weigh in on Regeneron stock's next move with options. The security's Schaeffer's Volatility Index (SVI) of 41% stands in the relatively low 20th percentile of its annual range. In other words, REGN currently sports attractively priced premiums.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI